000 | 01786 a2200481 4500 | ||
---|---|---|---|
005 | 20250517071105.0 | ||
264 | 0 | _c20171002 | |
008 | 201710s 0 0 eng d | ||
022 | _a1095-9319 | ||
024 | 7 |
_a10.1016/j.mvr.2015.12.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Wei | |
245 | 0 | 0 |
_aCurcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R. _h[electronic resource] |
260 |
_bMicrovascular research _c07 2016 |
||
300 |
_a117-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
650 | 0 | 4 |
_aBrain Edema _xmetabolism |
650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xmetabolism |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTranscription Factor RelA _xmetabolism |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aSuwanwela, Nijasri C | |
700 | 1 | _aPatumraj, Suthiluk | |
773 | 0 |
_tMicrovascular research _gvol. 106 _gp. 117-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mvr.2015.12.008 _zAvailable from publisher's website |
999 |
_c25558978 _d25558978 |